The company has no debt and 14 patents for a whole range of uses. In a worst case scenario (imo), it could be put up for auction and surely somebody will have it all for multiples of its current market capitalisation - after all it is a functional mTOR inhibitor with very low adverse effects, an excellent safety profile - look up mTOR inhibitors and their uses.
So either this will be a block buster or a decent earner.
(All my unsound opinion of course and don't bet your future financial life on it or any one stock)
The company has no debt and 14 patents for a whole range of...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33242 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 12.41pm 07/05/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable